[Leukostasis and tumor lysis: important complications of hyperleukocytosis].
The occurrence of hyperleukocytosis (leukocytes > 100.000/μl) is associated with complications such as leukostasis, tumor lysis and consumption coagulopathy in patients with acute leukemia much more often than in patients with chronic malignant hematological diseases. To manage these situations may be complex as organ failure is often imminent or manifest, infectious complications arise and indications for induction chemotherapy are usually urgent. Prophylaxis and therapy of the tumor lysis syndrome consists of hydration, lowering of uric acid and the management of electrolyte disturbances. Leukostasis requires immediate reduction of the leukocyte count by leukapheresis, administration of hydroxycarbamide and, ultimately, by causative and specific treatment of the underlying disease itself. In patients with curable diseases or favorable long-term prognosis, transfer to the intensive care unit must be evaluated early in the course of impending organ dysfunction, especially in cases of acute respiratory failure.
Universitätsklinik für Innere Medizin I, Intensivstation 13i2, Medizinische Universität Wien, Währinger Gürtel 18-20, 1090 Wien, Österreich. peter.schellongowski@meduniwien.ac.at
P
P
Schellongowski
T
T
Staudinger
D003422:Critical Care / Q000379:methods*; D006801:Humans; D007964:Leukocytosis / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D018921:Leukostasis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D015275:Tumor Lysis Syndrome / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*